Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Sentinel lymph node mapping in endometrial cancer - areas where further research is needed.

Obermair A, Abu-Rustum NR.

Int J Gynecol Cancer. 2020 Jan 17. pii: ijgc-2019-001089. doi: 10.1136/ijgc-2019-001089. [Epub ahead of print] No abstract available.

PMID:
31953348
2.

Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial.

Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, Rendon G, Ribeiro R, Tsunoda A, Behan V, Buda A, Bernadini MQ, Zhao H, Vieira M, Walker J, Spirtos NM, Yao S, Chetty N, Zhu T, Isla D, Tamura M, Nicklin J, Robledo KP, Gebski V, Coleman RL, Salvo G, Ramirez PT.

Am J Obstet Gynecol. 2019 Oct 3. pii: S0002-9378(19)31165-2. doi: 10.1016/j.ajog.2019.09.036. [Epub ahead of print]

PMID:
31586602
3.

The impact of team familiarity on surgical outcomes in gynaecological surgery.

Obermair A, Simunovic M, Janda M.

J Obstet Gynaecol. 2019 Sep 13:1-3. doi: 10.1080/01443615.2019.1636778. [Epub ahead of print] No abstract available.

PMID:
31519116
4.

A Bioimpedance Spectroscopy-Based Method for Diagnosis of Lower-Limb Lymphedema.

Steele ML, Janda M, Vagenas D, Ward LC, Cornish BH, Box R, Gordon S, Matthews M, Poppitt SD, Plank LD, Yip W, Rowan A, Reul-Hirche H, Obermair A, Hayes SC.

Lymphat Res Biol. 2019 Sep 5. doi: 10.1089/lrb.2018.0078. [Epub ahead of print]

PMID:
31486709
5.

How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial.

Obermair A, Armfield NR, Graves N, Gebski V, Hanna GB, Coleman MG, Hughes A, Janda M.

BMJ Open. 2019 May 9;9(5):e027155. doi: 10.1136/bmjopen-2018-027155.

6.

Minimally Invasive or Abdominal Radical Hysterectomy for Cervical Cancer. Reply.

Ramirez PT, Obermair A.

N Engl J Med. 2019 Feb 21;380(8):794-795. doi: 10.1056/NEJMc1816590. No abstract available.

PMID:
30786198
7.

Incidence of adverse events, preventability and mortality in gynaecological hospital admissions: A systematic review and meta-analysis.

Tanaka K, Eriksson L, Asher R, Obermair A.

Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):195-200. doi: 10.1111/ajo.12937. Epub 2019 Jan 20. Review.

PMID:
30663036
8.

How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?

Sanjida S, Janda M, McPhail SM, Kissane D, Couper J, Scott J, Obermair A.

Gynecol Oncol. 2019 Feb;152(2):339-345. doi: 10.1016/j.ygyno.2018.11.018. Epub 2018 Nov 19.

PMID:
30466808
9.

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.

Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A.

N Engl J Med. 2018 Nov 15;379(20):1895-1904. doi: 10.1056/NEJMoa1806395. Epub 2018 Oct 31.

PMID:
30380365
10.

Normative Interlimb Impedance Ratios: Implications for Early Diagnosis of Uni- and Bilateral, Upper and Lower Limb Lymphedema.

Steele ML, Janda M, Vagenas D, Ward LC, Cornish BH, Box R, Gordon S, Matthews M, Poppitt SD, Plank LD, Yip W, Rowan A, Reul-Hirche H, Obermair A, Hayes SC.

Lymphat Res Biol. 2018 Oct 2. doi: 10.1089/lrb.2017.0082. [Epub ahead of print]

PMID:
30280970
11.

Challenges and controversies in the conservative management of uterine and ovarian cancer.

Janda M, McGrath S, Obermair A.

Best Pract Res Clin Obstet Gynaecol. 2019 Feb;55:93-108. doi: 10.1016/j.bpobgyn.2018.08.004. Epub 2018 Aug 31. Review.

PMID:
30243603
12.

Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use.

Armfield NR, Janda M, Obermair A.

Int J Qual Health Care. 2019 May 1;31(4):283-288. doi: 10.1093/intqhc/mzy162.

PMID:
30060080
13.

Surgical approach to hysterectomy and barriers to using minimally invasive methods.

Janda M, Armfield NR, Kerr G, Kurz S, Jackson G, Currie J, Page K, Weaver E, Yazdani A, Obermair A.

Aust N Z J Obstet Gynaecol. 2018 Dec;58(6):690-695. doi: 10.1111/ajo.12824. Epub 2018 May 15.

PMID:
29763509
14.

The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.

Nagle CM, Crosbie EJ, Brand A, Obermair A, Oehler MK, Quinn M, Leung Y, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2018 Jul;150(1):99-105. doi: 10.1016/j.ygyno.2018.04.006. Epub 2018 Apr 26.

PMID:
29706522
15.

Endometrial cancer risk and survival by tumor MMR status.

Nagle CM, O'Mara TA, Tan Y, Buchanan DD, Obermair A, Blomfield P, Quinn MA, Webb PM, Spurdle AB; Australian Endometrial Cancer Study Group.

J Gynecol Oncol. 2018 May;29(3):e39. doi: 10.3802/jgo.2018.29.e39. Epub 2018 Feb 23.

16.

All-cause death in young women with endometrial cancer who receive progesterone therapy.

Obermair A, Janda M, Gebski V.

Am J Obstet Gynecol. 2018 Jul;219(1):119. doi: 10.1016/j.ajog.2018.03.009. Epub 2018 Mar 9. No abstract available.

PMID:
29530674
17.

LAP-VEGaS Practice Guidelines for Reporting of Educational Videos in Laparoscopic Surgery: A Joint Trainers and Trainees Consensus Statement.

Celentano V, Smart N, McGrath J, Cahill RA, Spinelli A, Obermair A, Hasegawa H, Lal P, Almoudaris AM, Hitchins CR, Pellino G, Browning MG, Ishida T, Luvisetto F, Cingiloglu P, Gash K, Harries R, Harji D, Di Candido F, Cassinotti E, McDermott FD, Berry JEA, Battersby NJ, Platt E, Campain NJ, Keeler BD, Boni L, Gupta S, Griffith JP, Acheson AG, Cecil TD, Coleman MG.

Ann Surg. 2018 Dec;268(6):920-926. doi: 10.1097/SLA.0000000000002725.

PMID:
29509586
18.

Disease-Free and Survival Outcomes for Total Laparoscopic Hysterectomy Compared With Total Abdominal Hysterectomy in Early-Stage Endometrial Carcinoma: A Meta-analysis.

Asher R, Obermair A, Janda M, Gebski V.

Int J Gynecol Cancer. 2018 Mar;28(3):529-538. doi: 10.1097/IGC.0000000000001199.

PMID:
29369119
19.

Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer.

Higgs P, Janda M, Asher R, Gebski V, Forder P, Obermair A.

Am J Obstet Gynecol. 2018 Apr;218(4):419.e1-419.e14. doi: 10.1016/j.ajog.2017.12.233. Epub 2018 Jan 2.

PMID:
29305254
20.

ER and PR expression and survival after endometrial cancer.

Smith D, Stewart CJR, Clarke EM, Lose F, Davies C, Armes J, Obermair A, Brennan D, Webb PM, Nagle CM, Spurdle AB.

Gynecol Oncol. 2018 Feb;148(2):258-266. doi: 10.1016/j.ygyno.2017.11.027. Epub 2017 Dec 6.

PMID:
29217139
21.

The relative risk of second primary cancers in Austria's western states: a retrospective cohort study.

Preyer O, Concin N, Obermair A, Concin H, Ulmer H, Oberaigner W.

BMC Cancer. 2017 Oct 24;17(1):699. doi: 10.1186/s12885-017-3683-9.

22.

Factors influencing women's decision making in hysterectomy.

Janda M, Armfield NR, Page K, Kerr G, Kurz S, Jackson G, Currie J, Weaver E, Yazdani A, Obermair A.

Patient Educ Couns. 2018 Mar;101(3):504-510. doi: 10.1016/j.pec.2017.09.006. Epub 2017 Sep 12.

PMID:
28918105
23.

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

Johnatty SE, Tan YY, Buchanan DD, Bowman M, Walters RJ, Obermair A, Quinn MA, Blomfield PB, Brand A, Leung Y, Oehler MK; ANECS Group, Kirk JA, O'Mara TA, Webb PM, Spurdle AB.

Gynecol Oncol. 2017 Nov;147(2):381-387. doi: 10.1016/j.ygyno.2017.08.011. Epub 2017 Aug 17.

PMID:
28822557
24.

Survival After Laparoscopic vs Abdominal Hysterectomy-Reply.

Gebski V, Janda M, Obermair A.

JAMA. 2017 Aug 8;318(6):574-575. doi: 10.1001/jama.2017.8165. No abstract available.

PMID:
28787501
25.

The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes.

Nicklin JL, McGrath S, Tripcony L, Garrett A, Land R, Tang A, Perrin L, Chetty N, Jagasia N, Crandon AJ, Nascimento M, Walker G, Sanday K, Obermair A.

Aust N Z J Obstet Gynaecol. 2017 Dec;57(6):651-658. doi: 10.1111/ajo.12665. Epub 2017 Jul 18.

PMID:
28718942
26.

Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.

Hayes SC, Janda M, Ward LC, Reul-Hirche H, Steele ML, Carter J, Quinn M, Cornish B, Obermair A.

Gynecol Oncol. 2017 Sep;146(3):623-629. doi: 10.1016/j.ygyno.2017.06.004. Epub 2017 Jun 16.

PMID:
28624154
27.

Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.

Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Robertson G, Walker G, Armfield NR, Graves N, McCartney AJ, Obermair A.

JAMA. 2017 Mar 28;317(12):1224-1233. doi: 10.1001/jama.2017.2068.

PMID:
28350928
28.

Nutrition interventions in patients with gynecological cancers requiring surgery.

Obermair A, Simunovic M, Isenring L, Janda M.

Gynecol Oncol. 2017 Apr;145(1):192-199. doi: 10.1016/j.ygyno.2017.01.028. Epub 2017 Feb 4. Review.

PMID:
28173966
29.

Cost-Efficiency of Robotic Surgery.

Covens A, Köhler C, Nam JH, Naumann RW, Obermair A, Querleu D.

Int J Gynecol Cancer. 2016 Jul;26(6):992-993. doi: 10.1097/IGC.0000000000000747. No abstract available.

PMID:
30814167
30.

Cost-Efficiency of Robotic Surgery.

Covens A, Köhler C, Nam JH, Naumann RW, Obermair A, Querleu D.

Int J Gynecol Cancer. 2016 Jul;26(6):992-3. doi: 10.1097/IGC.0000000000000747. No abstract available.

PMID:
27327148
31.

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy.

Obermair A, Brennan DJ, Baxter E, Armes JE, Gebski V, Janda M.

Gynecol Oncol Res Pract. 2016 Feb 9;3:1. doi: 10.1186/s40661-016-0023-8. eCollection 2016.

32.

Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.

Obermair A, Youlden D, Baade P, Janda M.

Asia Pac J Clin Oncol. 2017 Feb;13(1):68-78. doi: 10.1111/ajco.12508. Epub 2016 May 27.

PMID:
27230709
33.

Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.

Obermair H, Janda M, Obermair A.

Acta Obstet Gynecol Scand. 2016 Sep;95(9):1008-14. doi: 10.1111/aogs.12924. Epub 2016 Jun 10.

PMID:
27199208
34.

Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?

Kusters I, Williams M, Obermair A, Janda M.

J Community Support Oncol. 2015 Feb;13(2):55-61. doi: 10.12788/jcso.0109.

PMID:
25866984
35.

Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial.

Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, Chetty N, Crandon AJ, Land R, Nascimento M, Nicklin JL, Perrin LC, Obermair A.

Gynecol Oncol. 2015 Jun;137(3):516-22. doi: 10.1016/j.ygyno.2015.03.048. Epub 2015 Mar 28.

PMID:
25827292
36.

Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: results from the LACE trial.

Baker J, Janda M, Gebski V, Forder P, Hogg R, Manolitsas T, Obermair A.

Gynecol Oncol. 2015 Apr;137(1):102-5. doi: 10.1016/j.ygyno.2015.02.008. Epub 2015 Feb 14.

PMID:
25684217
37.

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.

Brennan DJ, Hackethal A, Mann KP, Mutz-Dehbalaie I, Fiegl H, Marth C, Obermair A.

BMC Cancer. 2015 Feb 6;15:33. doi: 10.1186/s12885-015-1028-0.

38.

Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australia.

Tan YY, Spurdle AB, Obermair A.

J Pers Med. 2014 May 12;4(2):218-44. doi: 10.3390/jpm4020218.

39.

Consideration for safe and effective gynaecological laparoscopy in the obese patient.

Hackethal A, Brennan D, Rao A, Land R, Obermair A, Nicklin J, Garrett A, Nascimento M, Crandon A, Perrin L, Chetty N.

Arch Gynecol Obstet. 2015 Jul;292(1):135-41. doi: 10.1007/s00404-014-3600-2. Epub 2014 Dec 23.

PMID:
25534161
40.

Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer.

Beesley VL, Rowlands IJ, Hayes SC, Janda M, O'Rourke P, Marquart L, Quinn MA, Spurdle AB, Obermair A, Brand A, Oehler MK, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2015 Jan;136(1):87-93. doi: 10.1016/j.ygyno.2014.11.006. Epub 2014 Nov 11.

PMID:
25448454
41.

Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.

Anuradha S, Webb PM, Blomfield P, Brand AH, Friedlander M, Leung Y, Obermair A, Oehler MK, Quinn M, Steer C, Jordan SJ.

Med J Aust. 2014 Sep 1;201(5):283-8.

PMID:
25163381
42.

Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.

Hawkes AL, Quinn M, Gebski V, Armes J, Brennan D, Janda M; feMME Trial Committee, Obermair A.

Contemp Clin Trials. 2014 Sep;39(1):14-21. doi: 10.1016/j.cct.2014.06.014. Epub 2014 Jul 1.

PMID:
24999075
43.

Reply to J. Moline et al.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB.

J Clin Oncol. 2014 Jul 20;32(21):2278-9. doi: 10.1200/JCO.2014.55.8213. Epub 2014 Jun 9. No abstract available.

PMID:
24912891
44.

Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer.

Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA, Brand A, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group.

Gynecol Oncol. 2014 May;133(2):314-8. doi: 10.1016/j.ygyno.2014.03.003. Epub 2014 Mar 11.

PMID:
24631452
45.

Comment on 'External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'.

Obermair A.

Br J Cancer. 2014 Dec 9;111(12):2375. doi: 10.1038/bjc.2014.8. Epub 2014 Jan 21. No abstract available.

46.

Can the use of quality assurance tools reduce the impact of surgical complications on the well-being of obstetricians and gynaecologists in Australia and New Zealand?

Varughese E, Janda M, Obermair A.

Aust N Z J Obstet Gynaecol. 2014 Feb;54(1):30-5. doi: 10.1111/ajo.12162. Epub 2013 Dec 23.

PMID:
24359293
47.

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, Young JP, Webb PM, Spurdle AB.

J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9.

48.

Serum HE4 as a prognostic marker in endometrial cancer--a population based study.

Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A.

Gynecol Oncol. 2014 Jan;132(1):159-65. doi: 10.1016/j.ygyno.2013.10.036. Epub 2013 Nov 6.

PMID:
24211402
49.

The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.

Obermair A, Youlden DR, Baade PD, Janda M.

Int J Cancer. 2014 May 1;134(9):2211-22. doi: 10.1002/ijc.28537. Epub 2013 Oct 31.

50.

Metastasis of ovarian cancer is mediated by kallikrein related peptidases.

Dong Y, Loessner D, Irving-Rodgers H, Obermair A, Nicklin JL, Clements JA.

Clin Exp Metastasis. 2014 Jan;31(1):135-47. doi: 10.1007/s10585-013-9615-4. Epub 2013 Sep 17. Review.

Supplemental Content

Loading ...
Support Center